Los puntos clave no están disponibles para este artículo en este momento.
Recent advances in nanomedicine have shown that dramatic improvements in nanoparticle therapeutics and diagnostics can be achieved through the use of disease specific targeting ligands.
Richards et al. (Fri,) studied this question.